Physician profile
Benjamin Kamp
NPI 1922266121
$2,359.68
in general payments reported to CMS, 2019-2025
15 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.67 · 2020: $58.76 · 2021: $18.40 · 2022: $180 · 2023: $1,441 · 2024: $74.74 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395 · Travel and Lodging: $623 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.65 |
| Travel and Lodging | $623.18 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,340.22 | 2021-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $272.00 | 2023-2025 | Transorb, Ligasure |
| Davol INC. | $201.06 | 2022-2023 | Phasix Mesh, Arista Ah Flexitip |
| Conmed Corporation | $152.09 | 2022-2025 | Airseal |
| Becton, Dickinson and Company | $128.06 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $56.77 | 2020-2022 | |
| Allergan, INC. | $48.12 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $30.78 | 2023 | Seglentis |
| Polynovo North America LLC | $26.63 | 2023 | |
| Tela Bio, INC. | $24.44 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $21.98 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.62 | 2025 | |
| Abbvie INC. | $15.69 | 2022 | |
| Convatec INC. | $11.63 | 2019 | |
| Smith+Nephew, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Kamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.